SCHEMBL27719002

SCHEMBL27719002

CC(C)(C)C(=O)ON1CCN(c2ncc(S(C)(=O)=O)s2)CC1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MLYCD O95822 3/20 0.39
HDAC3 O15379 8/20 0.36
HDAC4 P56524 8/20 0.36
HDAC1 Q13547 8/20 0.36
HDAC7 Q8WUI4 8/20 0.36
HDAC2 Q92769 8/20 0.36
HDAC10 Q969S8 8/20 0.36
HDAC11 Q96DB2 8/20 0.36
HDAC8 Q9BY41 8/20 0.36
HDAC6 Q9UBN7 8/20 0.36
HDAC9 Q9UKV0 8/20 0.36
HDAC5 Q9UQL6 8/20 0.36
TDP1 Q9NUW8 1/20 0.35
SCD O00767 1/20 0.34
GPR119 Q8TDV5 3/20 0.33
FFAR2 O15552 1/20 0.33
KCNJ1 P48048 1/20 0.33
TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28771983 0.88 HDAC3 (0.34) MLYCDHDAC3HDAC4HDAC1HDAC7
SCHEMBL27698724 0.84 HDAC3 (0.43) MLYCDHDAC3HDAC4HDAC1HDAC7
SCHEMBL27698697 0.83 NAMPT (0.41) MLYCDHDAC3HDAC4HDAC1HDAC7
SCHEMBL27698702 0.82 HDAC3 (0.41) MLYCDHDAC3HDAC4HDAC1HDAC7
SCHEMBL27698752 0.81 NAMPT (0.40) MLYCDHDAC3HDAC4HDAC1HDAC7
SCHEMBL2825192 0.81 GPR119 (0.50) GPR119
SCHEMBL27718997 0.79 HDAC3 (0.36) MLYCDHDAC3HDAC4HDAC1HDAC7
SCHEMBL27718993 0.79 MLYCD (0.44) MLYCD
SCHEMBL27556099 0.78 HRH3 (0.37) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL27698692 0.76 HDAC3 (0.34) MLYCDHDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101137363-B [4- (heteroaryl) piperazin-1-yl ] - (2, 5-substituted-phenyl) methanone derivatives as glycine transporter 1(GlyT-1) inhibitors for the treatment of neurological and neuropsychiatric disorders HOFFMANN LA ROCHE 2010-09-15 CN disclosed
CN-101137363-A [ 4- (heteroaryl) piperazin-1-yl ] - (2, 5-substituted-phenyl) methanone derivatives as glycine transporter 1 (GlyT-1) inhibitors for the treatment of neurological and neuropsychiatric disorders HOFFMANN LA ROCHE (CH) 2008-03-05 CN disclosed